Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights PART 05: Veterinary drug approval process • NADAs and supplements • ANADAs and supplements • CNADAs PART 06: Market Landscape • Market overview • Five forces analysis PART 07: Market segmentation by type of animals PART 08: Market segmentation by product category • Ectoparasiticides • Endoparasiticides • Endectocides PART 09: Geographical segmentation • Parasiticides market in Americas • Parasiticides market in EMEA • Parasiticides market in APAC PART 10: Decision framework PART 11: Drivers and challenges • Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments PART 12: Market trends • Vertical integration in livestock industry • Increase in R&D activities • Industry-academia collaborations PART 13: Vendor Landscape • Competitive scenario • Other prominent vendors PART 14: Key vendor analysis PART 15: Appendix • List of abbreviations List of Exhibits Exhibit 01: Parameters for FDA approval Exhibit 02: Overview of global animal parasiticides market Exhibit 03: Factors influencing global animal parasiticides market 2016 Exhibit 04: Global animal parasiticides market snapshot: Developed and emerging markets 2016 Exhibit 05: Global animal parasiticides market 2017-2021($ millions) Exhibit 06: Five forces analysis Exhibit 07: Global animal parasiticides market segments by type of animals Exhibit 08: Global animal parasiticides market by product category 2016 Exhibit 09: Global ectoparasiticides market 2016-2021 ($ millions) Exhibit 10: Global endoparasiticides market 2016-2021 ($ millions) Exhibit 11: Global endectocides market 2016-2021 ($ millions) Exhibit 12: Segmentation of global animal parasiticides market based on geography 2016 and 2021 Exhibit 13: Global animal parasiticides market revenue by geography 2016-2021 ($ millions) Exhibit 14: Market scenario in Americas Exhibit 15: Animal parasiticides market in Americas 2016-2021 ($ millions) Exhibit 16: Market scenario in EMEA Exhibit 17: Animal parasiticides market in EMEA ($ millions) Exhibit 18: Market scenario in APAC Exhibit 19: Animal Parasiticides market in APAC ($ millions) Exhibit 20: Impact of drivers and challenges in global animal parasiticides market Exhibit 21: Impact of drivers Exhibit 22: Impact of challenges Exhibit 23: Strategic success factors of companies in global animal parasiticides market Exhibit 24: Bayer HealthCare: Key highlights Exhibit 25: Bayer HealthCare: Strength assessment Exhibit 26: Bayer HealthCare: Strategy assessment Exhibit 27: Bayer HealthCare: Opportunity assessment Exhibit 28: Elanco: Key highlights Exhibit 29: Elanco: Strength assessment Exhibit 30: Elanco: Strategy assessment Exhibit 31: Elanco: Opportunity assessment Exhibit 32: Merck Animal Health: Key highlights Exhibit 33: Merck Animal Health: Strength assessment Exhibit 34: Merck Animal Health: Strategy assessment Exhibit 35: Merck Animal Health: Opportunity assessment Exhibit 36: Merial: Key highlights Exhibit 37: Merial: Strength assessment Exhibit 38: Merial: Strategy assessment Exhibit 39: Merial: Opportunity assessment Exhibit 40: Zoetis: Key highlights Exhibit 41: Zoetis: Strength assessment Exhibit 42: Zoetis: Strategy assessment Exhibit 43: Zoetis: Opportunity assessment

Bayer HealthCare, Elanco, Merck Animal Health, Merial, Zoetis, Animal Medics, Biogénesis Bagó, Bio-Vet, Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals, ECO Animal Health, Huvepharma, Indian Immunologicals, Lillidale Animal Health, Mobedco-Vet (The Arab Pesticides & Veterinary Drugs), Neogen, Norbrook, Orion, Phibro Animal Health, Vétoquinol, Virbac, and Vitafor.